SAN MARCOS, Calif.--(BUSINESS WIRE)--Seven years in development, the FDA cleared-to-market O²Misly™ Wound Treatment System is now available to the public. The system, developed by San Diego inventor Adrian Pelkus, uses Vaporous Hyperoxia Therapy, a newly patented process wherein oxygen is infused with a vapor which delivers an anti-microbial to the affected area. The anti-microbial mist stops infections, opens micro capillaries which encourages blood flow and the oxygen bath then encourages blood vessel growth.
